| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |